Alzheimer's disease: halothane induces Abeta peptide to oligomeric form--solution NMR studies

Affiliations

¹ Western Psychiatric Institute and Clinic, Department of Psychiatry, University of Pittsburgh Medical School, 3811 O'Hara Street, Pittsburgh, PA 15213, USA. mandalp@upmc.edu

Pravat K Mandal et al. Neurochem Res. 2008 Jan.

. 2008 Jan;33(1):220.

doi: 10.1007/s11064-007-9476-9.

¹ Western Psychiatric Institute and Clinic, Department of Psychiatry, University of Pittsburgh Medical School, 3811 O'Hara Street, Pittsburgh, PA 15213, USA. mandalp@upmc.edu

No abstract available

Retraction of

Alzheimer's disease: halothane induces Abeta peptide to oligomeric form--solution NMR studies.
Mandal PK, Pettegrew JW, McKeag DW, Mandal R. Mandal PK, et al. Neurochem Res. 2006 Jul;31(7):883-90. doi: 10.1007/s11064-006-9092-0. Epub 2006 Jun 29. Neurochem Res. 2006. Retraction in: Neurochem Res. 2008 Jan;33(1):220. doi: 10.1007/s11064-007-9476-9. PMID: 16807784 Retracted.

Alzheimer's disease: halothane induces Abeta peptide to oligomeric form--solution NMR studies.
Mandal PK, Pettegrew JW, McKeag DW, Mandal R. Mandal PK, et al. Neurochem Res. 2006 Jul;31(7):883-90. doi: 10.1007/s11064-006-9092-0. Epub 2006 Jun 29. Neurochem Res. 2006. Retraction in: Neurochem Res. 2008 Jan;33(1):220. doi: 10.1007/s11064-007-9476-9. PMID: 16807784 Retracted.
Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies.
Mandal PK, Pettegrew JW. Mandal PK, et al. Neurochem Res. 2004 Dec;29(12):2267-72. doi: 10.1007/s11064-004-7035-1. Neurochem Res. 2004. PMID: 15672549
Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions.
Narayanan S, Reif B. Narayanan S, et al. Biochemistry. 2005 Feb 8;44(5):1444-52. doi: 10.1021/bi048264b. Biochemistry. 2005. PMID: 15683229
Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
Kreutzer AG, Nowick JS. Kreutzer AG, et al. Acc Chem Res. 2018 Mar 20;51(3):706-718. doi: 10.1021/acs.accounts.7b00554. Epub 2018 Mar 6. Acc Chem Res. 2018. PMID: 29508987 Free PMC article. Review.
Vaccines for Alzheimer's disease: how close are we?
Janus C. Janus C. CNS Drugs. 2003;17(7):457-74. doi: 10.2165/00023210-200317070-00001. CNS Drugs. 2003. PMID: 12751917 Review.